InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,899.20
(
-0.94%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.51
(
0.33%
)
Bitcoin
63,887.50
(
-0.61%
)
Post# of 251590
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 91
Posts 17147
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: bladerunner1717 post# 142486

Wednesday, 05/23/2012 9:27:34 PM

Wednesday, May 23, 2012 9:27:34 PM

Post# of 251590

Dr. Ron Garren says that CLDX will try to do a small, single-arm study with PFS as the primary endpoint under "accelerated approval."



Wow.

Does not the FDA clearly not consider time based endpoints in single arm studies for registrational purposes (even accelerated)?

Who is smoking what?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up